Surgical management of invasive pulmonary aspergillosis in neutropenic patients

被引:63
|
作者
Bernard, A
Caillot, D
Couaillier, JF
Casasnovas, O
Guy, H
Favre, JP
机构
[1] UNIV BURGUNDY,DEPT SURG,DIJON,FRANCE
[2] UNIV BURGUNDY,DEPT CLIN HEMATOL,DIJON,FRANCE
[3] UNIV BURGUNDY,DEPT RADIOL,DIJON,FRANCE
来源
ANNALS OF THORACIC SURGERY | 1997年 / 64卷 / 05期
关键词
D O I
10.1016/S0003-4975(97)00858-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. The aim of our study was to clarify the indications for operation in invasive pulmonary aspergillosis. Methods. Nineteen patients with hematologic malignancy, in whom invasive pulmonary aspergillosis developed during the course of neutropenia, had operations. Neutropenia lasted 28 days (range, 15 to 45 days). The preoperative diagnosis of invasive pulmonary aspergillosis was based on computed tomographic scan findings (halo or air crescent signs). Results. Eight patients underwent emergency operations, before marrow recovery, for prevention of massive hemoptysis. The criterion for operation was an aspergillosis lesion that contacted the pulmonary artery on computed tomography. A lobectomy was performed in all cases. A sleeve resection of the pulmonary artery was necessary on two occasions. There was one postoperative death due to extensive aspergillosis. The length of hospitalization after operation was 13 days (range, 6 to 18 days). Seven patients were treated by elective resection of a residual mass (before hematologic therapy in 6 Cases). The types of resection performed were lobectomy (n = 4), lingulectomy (n = 1), and wedge resection (n = 2). There were no postoperative deaths. The average length of stay before discharge from the hospital was 11 days (range, 7 to 20 days). The surgical resection was performed as a diagnostic procedure in the 4 remaining patients after an allotted time of 14 days (range, 4 to 24 days) from initiation of antifungal therapy. Conclusions. The combination of antifungal agents and surgical resection is an efficient strategy for the treatment of invasive pulmonary aspergillosis iii patients with hematologic malignancy.
引用
收藏
页码:1441 / 1447
页数:7
相关论文
共 50 条
  • [31] Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients
    Behre, GF
    Schwartz, S
    Lenz, K
    Ludwig, WD
    Schilling, E
    Heinemann, V
    Link, H
    Boenisch, O
    Treder, W
    Siegert, W
    Wandt, H
    Trittin, A
    Hiddemann, W
    Beyer, J
    [J]. ANNALS OF HEMATOLOGY, 1995, 71 (06) : 287 - 291
  • [32] Treatment of invasive pulmonary aspergillosis in neutropenic patients by additional Bronchoscopic amphotericin B instillation
    Winkler, J.
    Muller, U.
    Nenoff, P.
    Seyfarth, H. -J.
    Vogtmann, M.
    Borte, G.
    Pönisch, W.
    Kahn, T.
    Wirtz, H.
    Schauer, J.
    Hoheisel, G.
    [J]. RESPIRATION, 2007, 74 (06) : 663 - 673
  • [33] Prophylactic use of itraconazole for the prevention of invasive pulmonary aspergillosis in high risk neutropenic patients
    Lamy, T
    Bernard, M
    Courtois, A
    Jacquelinet, C
    Chevrier, S
    Dauriac, C
    Grulois, I
    Guiguen, C
    Le Prise, P
    [J]. LEUKEMIA & LYMPHOMA, 1998, 30 (1-2) : 163 - 174
  • [34] Galactomannan detection in exhaled breath condensate of neutropenic patients with suspected invasive pulmonary aspergillosis
    Doffman, S. R.
    Griffiths, L. J.
    Athorn, G. R.
    Vinnicombe, S. J.
    Moore-Gillon, J. C.
    Griffiths, M. J.
    Agrawal, S. G.
    [J]. THORAX, 2007, 62 : A50 - A51
  • [35] Galactomannan Serves as a Surrogate Endpoint for Outcome of Pulmonary Invasive Aspergillosis in Neutropenic Hematology Patients
    Maertens, Johan
    Buve, Kristel
    Theunissen, Koen
    Meersseman, Wouter
    Verbeken, Eric
    Verhoef, Gregor
    Van Eldere, Johan
    Lagrou, Katrien
    [J]. CANCER, 2009, 115 (02) : 355 - 362
  • [36] EMERGENCY LUNG RESECTIONS FOR INVASIVE ASPERGILLOSIS IN NEUTROPENIC PATIENTS
    BERNARD, A
    LOIRE, J
    CAILLOT, D
    CASASNOVAS, O
    COUAILLER, JF
    GUY, H
    FAVRE, JP
    [J]. ANNALES DE CHIRURGIE, 1995, 49 (09): : 849 - 853
  • [37] Computed tomography findings in invasive pulmonary aspergillosis in non-neutropenic transplant recipients and neutropenic patients, and their prognostic value
    Park, Seong Yeon
    Lim, Chaehun
    Lee, Sang-Oh
    Choi, Sang-Ho
    Kim, Yang Soo
    Woo, Jun Hee
    Song, Jae-Woo
    Kim, Mi Young
    Chae, Eun Jin
    Do, Kyung-Hyun
    Song, Koun-Sik
    Seo, Joon Beom
    Kim, Sung-Han
    [J]. JOURNAL OF INFECTION, 2011, 63 (06) : 447 - 456
  • [38] Invasive pulmonary aspergillosis: effects of early resection in a neutropenic rat model
    Habicht, JM
    Preiss, M
    Passweg, J
    Dalquen, P
    Matt, P
    Adler, H
    Frei, R
    Zerkowski, HR
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2002, 22 (05) : 728 - 732
  • [39] Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications
    Todeschini, G
    Murari, C
    Bonesi, R
    Pizzolo, G
    Verlato, G
    Tecchio, C
    Meneghini, V
    Franchini, M
    Giuffrida, C
    Perona, G
    Bellavite, P
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1999, 29 (05) : 453 - 457
  • [40] INVASIVE PULMONARY ASPERGILLOSIS: AN UNCOMMON PRESENTATION IN A NON-NEUTROPENIC PATIENT
    Noland, Dillon
    [J]. CHEST, 2020, 158 (04) : 1409A - 1409A